Welcome to the 88th edition of the Research Digest. This edition features a study that aimed to determine the value of a simple, objective office-based test in the evaluation of OI and brain fog and large genetic association study that sought to identify chromosomal regions that may be linked to ME/CFS. Read more
You can also join our community and choose to have the Research Digest delivered straight to your inbox every month on a Friday afternoon by signing up to our mailing list here.
We appreciate the support of everyone who reads the Research Digest – we encourage regular subscribers to support us with a suggested donation of $2. You can donate here.
Welcome to the 87th edition of the Research Digest. This month's edition highlights emerging evidence of endothelial dysfunction, to further demonstrate the striking similarities of Long Covid to ME/CFS. The metabolism of tryptophan and the role of its metabolites are also presented and postulated to influence symptoms of ME/CFS, as well as suggested mechanisms that may be responsible for the neuroinflammation observed in both ME/CFS and Long Covid. Read more
Welcome to the 86th edition of the Research Digest. This edition reviews research articles looking further into infectious mononucleosis and its links with ME/CFS and the impact of ME/CFS, on the quality of life for patients and their partners. The digest also presents a recent ME/CFS brain imaging study that may prove useful diagnostically in the future and highlights the 2GB radio interview, featuring Emerge Australia’s CEO Anne Wilson, discussing the impact of changes to Telehealth. Read more
Welcome to the 85th edition of Emerge Australia’s Research Digest. As a special edition, this month’s digest recapitulates Emerge Australia’s ME/CFS Awareness Week Research Panel webinar, providing insight into how our local ME/CFS community is contributing to ME/CFS research in Australia; via their contributions to the ME/CFS Biobank and You+ME Registry Australia. Read more
Welcome to the Research Digest’s 84th edition. This month we recap research studies of ME/CFS endothelial cell dysfunction and how metabolomics may provide insight into ME/CFS, pre-and post-exercise. Also presented, is advice for the treatment of Long Covid patients, given the injustices experienced by those with ME/CFS and a very honest account of what lengths a person living with ME/CFS will go to, in the absence of ME/CFS treatments; accenting the dire need for vital ME/CFS research funding. Read more
Welcome to the 83rd edition of the Research Digest. This month’s edition features ME/CFS studies focused on orthostatic intolerance, the effects of Naltrexone on ME/CFS NK cells, as well as a promising ME/CFS eye movement diagnostic tool. This edition also highlights Emerge Australia’s radio interviews featuring Anne Wilson, our CEO campaigning for an update to the ME/CFS guidelines and Richard Schloeffel (our Medical Director) calling out the disbelief of ME/CFS as “Medical Abuse Syndrome”. Read more
Welcome to the 82nd edition of the Research Digest. This month’s edition features studies investigating blood flow abnormalities that may contribute to the pathogenesis of ME/CFS and how lessons learnt from heat stroke may be useful to better understand ME/CFS. Further analysis of Long Covid and its overlap with ME/CFS symptomology is also presented with future research areas postulated. And last but not least, we present highlights from Anne Wilson’s recent radio interview on ABC Life Matters, Read more
Welcome to the 81st edition of the Research Digest. This edition reviews research articles investigating the potential of the cortical autonomic network, to act as a therapeutic target for ME/CFS symptom management, the involvement of C1q in ME/CFS pathology and more evidence demonstrating a linkage between ME/CFS and Long Covid. The highlights from a radio interview featuring Emerge Australia’s CEO Anne Wilson on 2GB, are also presented. Read more
Welcome to the 80th edition of the Research Digest. This edition summarises research papers trialling CT38s to investigate the involvement of the corticotropin-releasing factor system in ME/CFS and an Australian study observing the impact of life stressors, on those living with ME/CFS. The 80th and final edition of the research digest is concluded for 2021, with Emerge Australia’s full-page advertisement in the AFR, providing ME/CFS a voice in the national Long COVID conversation. Read more